U.S. markets closed
  • S&P 500

    3,825.33
    +39.95 (+1.06%)
     
  • Dow 30

    31,097.26
    +321.86 (+1.05%)
     
  • Nasdaq

    11,127.84
    +99.14 (+0.90%)
     
  • Russell 2000

    1,727.76
    +19.77 (+1.16%)
     
  • Crude Oil

    110.66
    +2.23 (+2.06%)
     
  • Gold

    1,808.30
    +6.80 (+0.38%)
     
  • Silver

    19.82
    +0.22 (+1.14%)
     
  • EUR/USD

    1.0426
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    2.8890
    0.0000 (0.00%)
     
  • GBP/USD

    1.2102
    -0.0001 (-0.01%)
     
  • USD/JPY

    135.7040
    +0.5290 (+0.39%)
     
  • BTC-USD

    19,755.81
    +302.60 (+1.56%)
     
  • CMC Crypto 200

    428.92
    +8.78 (+2.09%)
     
  • FTSE 100

    7,232.65
    +64.00 (+0.89%)
     
  • Nikkei 225

    26,153.81
    +218.19 (+0.84%)
     

Medical Properties (MPW) Stock Moves -0.87%: What You Should Know

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

In the latest trading session, Medical Properties (MPW) closed at $15.99, marking a -0.87% move from the previous day. This change was narrower than the S&P 500's 2.91% loss on the day. Meanwhile, the Dow lost 2.73%, and the Nasdaq, a tech-heavy index, lost 0.25%.

Heading into today, shares of the health care real estate investment trust had lost 9.79% over the past month, lagging the Finance sector's gain of 1% and the S&P 500's gain of 0.84% in that time.

Medical Properties will be looking to display strength as it nears its next earnings release. In that report, analysts expect Medical Properties to post earnings of $0.45 per share. This would mark year-over-year growth of 4.65%. Meanwhile, our latest consensus estimate is calling for revenue of $398.75 million, up 4.44% from the prior-year quarter.

MPW's full-year Zacks Consensus Estimates are calling for earnings of $1.84 per share and revenue of $1.62 billion. These results would represent year-over-year changes of +5.14% and +4.81%, respectively.

It is also important to note the recent changes to analyst estimates for Medical Properties. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.11% lower. Medical Properties currently has a Zacks Rank of #4 (Sell).

In terms of valuation, Medical Properties is currently trading at a Forward P/E ratio of 8.75. Its industry sports an average Forward P/E of 13.41, so we one might conclude that Medical Properties is trading at a discount comparatively.

We can also see that MPW currently has a PEG ratio of 0.88. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The REIT and Equity Trust - Other industry currently had an average PEG ratio of 2.41 as of yesterday's close.

The REIT and Equity Trust - Other industry is part of the Finance sector. This group has a Zacks Industry Rank of 166, putting it in the bottom 35% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

You can find more information on all of these metrics, and much more, on Zacks.com.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
To read this article on Zacks.com click here.